FDA to Centralize Enforcement, Specialize Workforce

Drug GMP Report

Mar. 04, 2014

The FDA will create a pharma-only enforcement unit that promises more consistent inspections and enforcement decisions with fewer bureaucratic hurdles for investigators to issue warning letters.
Read More